
In a cohort of 442 patients, HFsnEF showed similar risk for cardiovascular death or hospitalization as heart failure with reduced ejection fraction (HFrEF), despite distinct structural and proteomic profiles. HFsnEF was marked by increased wall thickness and unique plasma biomarkers, indicating a need for updated classification and tailored management strategies.
Like
Save
Share